Hôpital Aziza Othmana
About Hôpital Aziza Othmana
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Groupe Francophone des Myelodysplasies
1
Millennium Pharmaceuticals, Inc.
1
Clinical Trials at Hôpital Aziza Othmana
During the past decade, Hôpital Aziza Othmana conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
2008-05-01
2017-06-17
Completed
487
Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes
2010-12-30
2016-05-09
Completed
41
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Aziza Othmana"
#1 collaborator was "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hôpital Aziza Othmana
According to Clinical.Site data, the most researched conditions in "Hôpital Aziza Othmana" are
"High Grade Myelodysplastic Syndrome Lesions" (1 trials) and "Mantle Cell Lymphoma" (1 trials). Many other conditions were trialed in "Hôpital Aziza Othmana" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Aziza Othmana
Most popular intervention types in "Hôpital Aziza Othmana" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide 750 mg/m^2" (1 trials), "Doxorubicin 50 mg/m^2" (1 trials), "Prednisone 100 mg/m^2" (1 trials), "Rituximab 375 mg/m^2" (1 trials) and "VELCADE 1.3 mg/m^2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Aziza Othmana
The vast majority of trials in "Hôpital Aziza Othmana" are
2 trials for "All" genders.
Clinical Trials Status at Hôpital Aziza Othmana
Currently, there are NaN active trials in "Hôpital Aziza Othmana".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hôpital Aziza Othmana,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Aziza Othmana, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".